CLR 131
DCL-17-001
Phase 1 small_molecule active
Quick answer
CLR 131 for Pediatric Solid Tumor is a Phase 1 program (small_molecule) at Cellectar Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cellectar Biosciences
- Indication
- Pediatric Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active